Pharma BD Deal Intelligence

Shire plc / Advanced BioHealing, Inc.

2011 · Acquisition/Merger · $750M · Complete

Announcement Sentiment

Neutral / mixed

Shire acquired Advanced BioHealing for $750M cash to establish a regenerative medicine business unit; lead asset Dermagraft was an FDA-approved bioengineered skin substitute for diabetic foot ulcers. Closed Q3 2011.

Did it work? Outcome assessment

Strategic verdict

Failed to Achieve

Financial impact

Impaired/Written Down

Pipeline outcome

Assets Stalled

Assessment window: 10yr post-close.

Key facts

Announced May 17, 2011
Closed Jun 28, 2011
Deal value $750M
Deal type Acquisition/Merger
Therapeutic area Diabetic foot ulcers
Indications Diabetic foot ulcers
Key assets Dermagraft (cryopreserved human-fibroblast dermal substitute)
Mechanism Cryopreserved allogeneic neonatal dermal fibroblast scaffold

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals